| ￥2600 | |
| Z04250 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity |
>?95%?as?determined?by?Bis-Tris?PAGE >?95%?as?determined?by?HPLC |
||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Fc gamma RIIA/CD32a (H167), His & Avi, Human captured on CM5 Chip via anti-his antibody can bind Rituximab in SPR assay (Biacore T200). Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 23.2 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 30-40 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of Fc gamma RIIA/CD32a (H167), His & Avi, Human is greater than 95% as determined by SEC-HPLC. ?
Fc gamma RIIA/CD32a (H167), His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. ?
Fc gamma RIIA/CD32a (H167), His & Avi, Human , His Tag captured on CM5 Chip via anti-his antibody can bind Rituximab with an affinity constant of 1.53 μM as determined in SPR assay (Biacore T200) (QC Test). ?
| Target Background | The Fc gamma Rs have been divided into three classes based on close relationships in their extracellular domains; these groups are designated Fc gamma RI (also known as CD64), Fc gamma RII (CD32), and Fc gamma RIII (CD16). Each group may be encoded by multiple genes and exist in different isoforms depending on species and cell type. |
| Synonyms | FcgammaRIIA; Fc gammaRIIA; Fcgamma RIIA; Fc gamma RIIA; FcγRIIA; Fc γRIIA; Fcγ RIIA; Fc γ RIIA; FcgRIIA; Fc gRIIA; Fcg RIIA; Fc g RIIA; FCG2; FCGR2; FCGR2A; FCGR2A1; FCRIIA; fcRII-a; FCG2; CD32A |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
